News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

UK Trade & Investment Release: UK Wins Bio-IT World's 2005 Best Practices Award For Stem Cell Innovation


10/19/2005 5:09:24 PM

NEW YORK, June 29 /PRNewswire/ -- UK Trade & Investment, the British Government's international business development agency, accepted the Bio-IT World's 2005 Best Practices Award at last night's Bio-IT World Awards dinner in Washington DC. The UK received the award in the category of "Knowledge Management and Collaboration" for its global model of best practices in stem cell innovation.

"The future of the entire health sciences arena is essentially being dictated by the advances that are resulting from the model that the UK Government has established through its unambiguous, robust and ethical policy on stem cells", said Dr. Stefan Winkler, Vice Consul Science and Technology. "By setting the gold standard in stem cell policy, the UK Government has set the stage for technological stem cell innovation around the world and is fostering an environment where the future of global biomedicine can thrive."

Despite current debate over the use of stem cells and its consequent hindrance to progress, the UK Government has taken a clear stance and in the past year, implemented a progressive platform that includes dedicated resources, funding and collaboration among academic, government and commercial stakeholders. As a result, the Government has created a regulatory framework that fosters an environment of international collaboration and "best in class" research and development programs that are responsible for biomedical breakthroughs across the world today.

In May of 2004, the UK Government took a prominent global stance through the establishment of a $4.7 million public stem cell bank. Adhering to the highest regulatory and technology standards, the bank provides a global access to ethically approved and quality controlled cell lines for use in the development of clinical applications and basic research.

"The UK Trade & Investment entry for the UK really stood out in the minds of the judging panel," explained Bio-IT World editor-in-chief Kevin Davies. "There is no doubt about the incredible potential of stem cell technology. This award recognizes the great strides being made in the UK to stimulate innovation in this field, and to facilitate global research through the stem cell bank. It may also serve as a wake-up call to other countries that are in danger of falling behind in this critical area."

The UK Trade & Investment's entry was peer-reviewed by a panel of expert judges and selected from among 33 lengthy submissions from organizations ranging from large pharmaceutical and biotechnology companies to academic institutions, detailing best practices in one of six categories.

About UK Trade & Investment

UK Trade & Investment is the British Government's international business development agency, supporting companies in the UK doing business internationally and overseas enterprises seeking to establish a market footprint in the UK. The integrated services offered by UK Trade & Investment bring together a network of business sector specialists and support teams in over 200 British embassies and Foreign and Commonwealth Office (FCO) posts overseas, as well as key experts in government departments across the UK.

As a government agency, UK Trade & Investment is uniquely positioned to offer expanding companies access to a growing network of global business advisors and bespoke market entry intelligence and guidance on operational issues. With its government connections, in-depth knowledge of UK regional business, ties to leading institutions, science and technology resources, as well as its global network, UK Trade & Investment is a unique strategic resource for companies that want to operate in the number one business location in Europe. For more information visit: http://www.uktradeinvestusa.com

About Bio-IT World, Inc.

A business unit of IDG, Bio-IT World, Inc., publishes information across a variety of media to meet the needs of bio-IT, life science, healthcare, pharmaceutical and regulatory professionals. The company's award-winning publication, Bio-IT World, and accompanying website, http://www.bio-itworld.com, deliver the latest news, analysis and information on the application of technology products and services to enable the life sciences R&D value chain -- spanning basic research, drug discovery and development, clinical trials, and regulatory compliance. The company's digital magazine, Health-IT World, and twice-weekly electronic publication, Health-IT World News, cover business, technology and product developments related to healthcare management systems and outcomes-based medicine. Established in September 2001, Bio-IT World, Inc. is headquartered in Framingham, Mass.

For additional information about UKTI and its resources and services, please visit UK Trade & Investment's website at http://www.uktradeinvestusa.com or for general queries, contact:

Charlotte Simcock Daniel Bingham UK Trade & Investment Hill & Knowlton ph: (212) 745-0415 ph: (212) 885-0510 Charlotte.Simcock@fco.gov.uk daniel.bingham@hillandknowlton.com

UK Trade & Investment

CONTACT: Charlotte Simcock of UK Trade & Investment, +1-212-745-0415,Charlotte.Simcock@fco.gov.uk; Daniel Bingham for Hill & Knowlton,+1-212-885-0510, Daniel.bingham@hillandknowlton.com


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES